Showing 1 - 6 of 6
death), hospital utilization, and medical expenditure in Greece during the period 1995-2010. The estimates indicate that … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …
Persistent link: https://www.econbiz.de/10011122677
macroeconomics. The current policy, however, provides a credible platform for sustainable growth. Greece has entered the process of …-se determining growth, supply-side reforms and institutional performance are; and for Greece both are better served within the EMU …
Persistent link: https://www.econbiz.de/10010948838
of the restructuring left money on the table from the perspective of Greece, created a large risk for European taxpayers …
Persistent link: https://www.econbiz.de/10010679378
We describe the evolution of the power struggle in Greece among key economic and political stakeholders, who have tried …
Persistent link: https://www.econbiz.de/10010679379
and current account deficits, which have in turn driven Greece’s foreign indebtedness to alarming levels, necessitating …
Persistent link: https://www.econbiz.de/10008572540
This paper examines the long run education and labor market effects from early-life exposure to the Greek 1941-42 famine. Given the short duration of the famine, we can separately identify the famine effects for cohorts exposed in utero, during infancy and at one year of age. We find that...
Persistent link: https://www.econbiz.de/10008583697